Bittensor >> Subnet 85 >> Vidaio >> @vidaio_
But what is Gareth trying to tell us? 👀
Vidaio is clearly still flying under a lot of people’s radar.
Yet at Exploit Summit, Gareth jokingly talked about “the announcement of the announcement”… and ever since, I’ve been keeping a close eye on SN85.
His latest post particularly caught my attention. Major companies are now willing to pay for AI-powered video when it delivers tangible improvements to their existing workflows.
So I have to wonder: is this simply an observation about where the market is heading, or is Gareth preparing us for something?
Can Vidaio become the intelligence layer that transforms and enhances existing footage? And more importantly, are we getting close to the point where demos turn into partnerships, customers, and products being sold to the industry?
The technology is here. The market seems to be here.
Is this the calm before the storm?
@Gareth_Vidaio , what are you cooking? 😶🌫️
https://t.co/XtFoAKz7xi
@Neo__Hq Ye like America will just hand over the world’s biggest genius to Britain. He’s americas best asset and they wouldn’t want him in any other country’s hands.
I just got laid off today for the first time in my life.
It was a company wide layoff that affected 15% of employees and I got caught off guard, so it hurts.
Corporate America is a wild ride, where the only thing that matters to a public company is the stock performance.
I understand it, it’s just a bitter feeling after caring so much, for so long.
$TAO World:
I have 15+ years of Enterprise Sales experience in Technology, I am ready to be of any help to any subnet or company in the ecosystem that is hiring.
UPDATE: ANDREW & TRISTAN TATE ARE IN SOLITARY CONFINEMENT
Days ago, Andrew and Tristan Tate exercised their constitutional rights by visiting the US Capitol in Washington, D.C. They held meetings about their UK party, the midterms, and 2028. They also met with friends and members of Congress.
Now they sit in a 5x12 cell as political prisoners on American soil, in SOLITARY CONFINEMENT.
Make no mistake about it: they are being punished for daring to exercise their First Amendment Rights.
They are also being hunted by a despotic UK Government that wants to bury them in a foreign prison for the rest of their lives.
We met with them today. They are dressed in orange jumpsuits like Al Qaeda terrorists at Guantanamo Bay. Two innocent men, charged with nothing in America, dressed like enemy combatants.
Florida AG James Uthmeier, a low-testosterone deep state asset who hates free speech, tweeted "How the turntables…" celebrating the arrest of two innocent men, because he's a sad joke of a man who can't get over the fact that we wiped the floor with him last year.
This is un-American and unconscionable.
Love Andrew and Tristan or hate them. It does not matter.
When American citizens can be caged for their politics, every single one of you is next.
Mark my words, today it is Andrew and Tristan.
Tomorrow it will be Trump.
Then it will be you.
We have court first thing tomorrow.
Let your voices be heard.
Speak out. Now.
@InvestorJordan@CryptoMcDreamy Iv bought all the way up and all the way back down, and I’ll buy all the way up again untill it’s out my price range.
Conviction. 💎 $TAO
@harryjbjackson@Kimbou128 I like your presence with the community, reminds me of @MaxScore . Consistent updates and engaging . Keep up the good work 👌🤝
Good morning crypto!
And today is a big one…
🚀 $DIA token launch day.
After months of building, refining the strategy, and laying the foundation for a real diabetes research recruitment platform, @DiabetesDAO takes the next step.
Excited to see this go live.
#DeSci #DiabetesDAO #DIA
🚀🚀🚀 EXCITING NEWS: Our study recruitment platform is now LIVE!!! 🚀🚀🚀
This is the KEY product behind our strategy.
A simple way for people with diabetes to discover and participate in research such as clinical trials and real-world evidence (RWE) studies.
All web3 components are abstracted into the backend, as we are appealing to the broader masses beyond just our DeSci community.
By making participation easy, we can recruit cohorts faster and enable our research partners to run studies more efficiently. Most notably, all consented data is queryable by AI agents, enabling even faster study recruitment. As you’re probably aware, the first study we’re targeting is analyzing the impact of the menstrual cycle on glucose control in women with T1D.
This transforms DiabetesDAO from an online community into scalable research infrastructure.
What this enables:
- Faster, repeatable study recruitment and execution
- The ability to grow and engage a global patient network
- Stronger partnerships with research teams in medtech, pharma, and clinics
Next steps:
- Execute our flagship research study
- Integrate health data sources including CGMs, insulin pumps, and wearables
- Grow our partner and study pipeline globally
By providing real-world value to diabetes research outside of the original DeSci bubble, we aim to build a sustainable business model that is FAR GREATER than any of our past approaches.
This is the first step toward becoming the WORLD’S LARGEST patient-powered diabetes research network. Let’s scale this together!!!
Join the platform: https://t.co/bt3YaUgq0R
🚀🚀🚀 EXCITING NEWS: Our study recruitment platform is now LIVE!!! 🚀🚀🚀
This is the KEY product behind our strategy.
A simple way for people with diabetes to discover and participate in research such as clinical trials and real-world evidence (RWE) studies.
All web3 components are abstracted into the backend, as we are appealing to the broader masses beyond just our DeSci community.
By making participation easy, we can recruit cohorts faster and enable our research partners to run studies more efficiently. Most notably, all consented data is queryable by AI agents, enabling even faster study recruitment. As you’re probably aware, the first study we’re targeting is analyzing the impact of the menstrual cycle on glucose control in women with T1D.
This transforms DiabetesDAO from an online community into scalable research infrastructure.
What this enables:
- Faster, repeatable study recruitment and execution
- The ability to grow and engage a global patient network
- Stronger partnerships with research teams in medtech, pharma, and clinics
Next steps:
- Execute our flagship research study
- Integrate health data sources including CGMs, insulin pumps, and wearables
- Grow our partner and study pipeline globally
By providing real-world value to diabetes research outside of the original DeSci bubble, we aim to build a sustainable business model that is FAR GREATER than any of our past approaches.
This is the first step toward becoming the WORLD’S LARGEST patient-powered diabetes research network. Let’s scale this together!!!
Join the platform: https://t.co/bt3YaUgq0R
@DiabetesDAO is aiming far beyond a small DeSci community.
The strategy: build a mainstream diabetes research recruitment platform that millions can use, without forcing crypto complexity.
$DIA powers the ecosystem as it grows.
Over the past 12 months, we’ve been building and refining DiabetesDAO.
On February 19th, the DiabetesDAO token launches.
This marks an important step in expanding our ecosystem as we continue developing our research recruitment platform.
We appreciate your continued support.
More details soon.
🔥💙
Mel Gibson isn't lying…. A recent study documented COMPLETE REMISSION of Stage IV cancers using fenbendazole.
Patients with advanced melanoma, breast, and prostate cancer saw their tumors disappear — without chemotherapy.
Clinical trials must be launched immediately.